A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Public ClinicalTrials.gov record NCT00474188. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Lenalidomide (Revlimid ®) in Combination With Dexamethasone in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the safety and efficacy of lenalidomide (Revlimid ®) in combination with dexamethasone in subjects with relapsed or refractory diffuse large B-cell lymphoma.
Study identification
- NCT ID
- NCT00474188
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2007
- Primary completion
- Nov 30, 2008
- Completion
- Nov 30, 2008
- Last update posted
- Sep 1, 2009
2007 – 2008
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Palo Verde Hematology/Oncology, Ltd. | Glendale | Arizona | 85304 | — |
| Tower Cancer Research Foundation | Beverly Hills | California | 90211 | — |
| Advanced Medical Specialties | Miami | Florida | 33176 | — |
| Hematology/Oncology Associates of Treasure Coast | Port Saint Lucie | Florida | 34952 | — |
| Northwest Georgia Oncology Centers | Marietta | Georgia | 30060 | — |
| Cancer Care & Hematology Specialists of Chicagoland | Arlington Heights | Illinois | 60005 | — |
| Northwestern University, Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| Southwest Oncology Associates | Lafayette | Louisiana | 70503 | — |
| Washington County Hospital, The Center for Clinical Research | Hagerstown | Maryland | 21742 | — |
| Kalamazoo Hematology & Oncology | Kalamazoo | Michigan | 49048 | — |
| Oncology & Hematology Specialists, PA | Denville | New Jersey | 07834 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Northwestern Carolina, Oncology and Hematology PA | Hickory | North Carolina | 28602 | — |
| New Bern Cancer Care | New Bern | North Carolina | 28562 | — |
| James Cancer Hospital | Columbus | Ohio | 43210 | — |
| SouthWest Regional Cancer Center | Austin | Texas | 78705 | — |
| Northern Utah Associates | Ogden | Utah | 84403 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00474188, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2009 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00474188 live on ClinicalTrials.gov.